thanks Grip. you're right - it's still hard to believe (and sad) how much damage Nader did to this company. i think the new guy (Cyrus) under-estimated how much the well had been poisoned with the FDA- and it literally cost him his health. i feel for the poor guy - as a long-term investor, i could've bought him a beer and warned him what he was getting himself into.
it will be telling what happens now - will we be able to attract a decent CEO? it can't be an easy sell at this point to get someone to hitch their wagon to a company under clinical hold, and with limited funds. but that will guide my decision. if we get someone who is somewhat impressive and with a good plan on how to get on track, i'll continue to stick it out. if we get someone from the bush leagues, i may just mail it in and write this one off.
good luck to you also.